Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.
about
FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis.Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders.Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion.Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy.Cell sources for in vitro human liver cell culture models.Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform.Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications.Challenges on the road to a multicellular bioartificial liver.Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor.Hepatic differentiation of human iPSCs in different 3D models: A comparative study.Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.Cholangiopathies - Towards a molecular understanding
P2860
Q33613352-57EA313F-5D06-4E77-96FE-37435F19A266Q36023026-EDCF586A-7AAA-4F12-AEC4-9082D57CAF8AQ36218507-36D492FC-7820-4D50-8A87-1761B814E850Q36661790-2C5A01B4-13A8-49CC-A978-A31365161D31Q37208518-9BD46A6B-6CEE-4A90-B993-F45A2EF53F93Q37246493-91D17739-5900-4C5F-B3D2-AC0F2754FCFDQ38774569-E76C3CFC-6F09-4605-B822-31F9CB2DF3A8Q39036360-4D2AE11D-98C4-4342-8469-FDA31A335088Q40965254-6B3544FB-F109-4B09-8032-A9ACB76DC74BQ47137248-1AB2F659-E493-4CB1-A465-BBC042FA2D64Q47690325-BE2A7033-70FE-4EB5-B373-A28EA9E25A35Q48821774-70D56C3C-6315-41D1-8E21-EC0412525DE5Q53098241-B65FD522-EE23-42CB-8497-A2A6FAFCACF0Q57109524-D30B9FE6-2C79-47C6-9196-5B658B537F86
P2860
Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development and characterizati ...... m cell-derived cholangiocytes.
@ast
Development and characterizati ...... m cell-derived cholangiocytes.
@en
type
label
Development and characterizati ...... m cell-derived cholangiocytes.
@ast
Development and characterizati ...... m cell-derived cholangiocytes.
@en
prefLabel
Development and characterizati ...... m cell-derived cholangiocytes.
@ast
Development and characterizati ...... m cell-derived cholangiocytes.
@en
P2093
P2860
P1476
Development and characterizati ...... m cell-derived cholangiocytes.
@en
P2093
Bing Q Huang
Gwen A Lomberk
Jaime I Davila
Mary C Drinane
Nidhi Jalan-Sakrikar
Raul A Urrutia
Ruisi Wang
Steven P O'Hara
Thiago M De Assuncao
P2860
P2888
P304
P356
10.1038/LABINVEST.2015.51
P577
2015-04-13T00:00:00Z
P5875
P6179
1021695356